OpenAI
OpenAI acquires Orchestra Bio
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
Summary from the publisher's feed.
More in AI labs
- 12 NovMicrosoft Research Focus – Edition #98Microsoft Research
- 12 NovHow Amplitude ships product improvements in 1–2 days with OpenAIOpenAI
- 12 NovGoogle Search gets a major upgrade with Gemini 4 HydrogenGoogle AI
- 12 NovGondola doubles revenue as its team builds more with CodexOpenAI
- 12 NovHoliday Extras is rethinking what it can build with CodexOpenAI
- 12 NovSupporting research on AI and children’s safetyOpenAI
- 11 NovGemini Decisions API: Fast, calibrated multimodal decisionsGoogle AI
- 11 NovTry Tabletop: Customizable, collaborative spaces for groups to plan, play and do more together.Google AI